We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBR icon
676
Petrobras
PBR
$116B
$590K 0.01%
37,065
-3,200
-8% -$50.8K
DECK icon
677
Deckers Outdoor
DECK
$13.6B
$588K 0.01%
24,000
– –
ARE icon
678
Alexandria Real Estate Equities
ARE
$8.96B
$570K 0.01%
+4
New +$527
PBYI icon
679
Puma Biotechnology
PBYI
$407M
$567K 0.01%
14,614
-331,123
-96% -$10.1M
HAIN icon
680
Hain Celestial
HAIN
$46M
$555K 0.01%
+24,000
New +$463K
CRUS icon
681
Cirrus Logic
CRUS
$6.87B
$547K 0.01%
13,000
– –
IMO icon
682
Imperial Oil
IMO
$60.8B
$542K 0.01%
19,837
+1,667
+9% +$45.4K
NWL icon
683
Newell Brands
NWL
$2.2B
$540K 0.01%
35,212
– –
EPR icon
684
EPR Properties
EPR
$4.85B
$538K 0.01%
7,000
– –
TRMK icon
685
Trustmark
TRMK
$2.71B
$538K 0.01%
16,000
– –
RGLD icon
686
Royal Gold
RGLD
$17.1B
$535K 0.01%
+5,885
New +$514K
XPO icon
687
XPO
XPO
$24.4B
$534K 0.01%
28,706
+5,465
+24% +$105K
AUY
688
DELISTED
Yamana Gold, Inc.
AUY
$529K 0.01%
+203,052
New +$526K
WRI
689
DELISTED
Weingarten Realty Investors
WRI
$529K 0.01%
18,000
– –
UAA icon
690
Under Armour
UAA
$3.02B
$525K 0.01%
24,813
+5,536
+29% +$116K
ASX icon
691
ASE Group
ASX
$80.2B
$498K 0.01%
115,445
– –
FDS icon
692
Factset
FDS
$9.46B
$497K 0.01%
2,000
– –
OHI icon
693
Omega Healthcare
OHI
$15.3B
$496K 0.01%
13,000
– –
CSL icon
694
Carlisle Companies
CSL
$13.8B
$491K 0.01%
4,000
-79,705
-95% -$9.2M
ATH
695
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$482K 0.01%
11,815
-1,604
-12% -$68.7K
MPT
696
Medical Properties Trust
MPT
$2.86B
$481K 0.01%
26,000
– –
PZZA icon
697
Papa John's
PZZA
$997M
$477K 0.01%
9,000
– –
GH icon
698
Guardant Health
GH
$19.3B
$476K 0.01%
+6,200
New +$344K
RYN icon
699
Rayonier
RYN
$6.52B
$473K 0.01%
+16,533
New +$441K
MO icon
700
Altria Group
MO
$122B
$470K 0.01%
8,180
– –
26 27
28
29 30

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.